CHMP recommends Keytruda-chemo combo in squamous NSCLC

This article was originally published here

The CHMP’s positive opinion for Keytruda in combination with carboplatin and either paclitaxel or nab-paclitaxel is for the first-line treatment of metastatic NSCLC in adults. Keytruda is an

The post CHMP recommends Keytruda-chemo combo in squamous NSCLC appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply